Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q3 2021 · 10-Q
Revenue$14.45M$14.45M+0.4% vs Q3 2020 Net Income-$10.94M-$10.94MN/M vs Q3 2020 EPS Diluted-$1.31-$1.31N/M vs Q3 2020 Gross Profit$1,784,000−59.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,698,000N/M Margins · derivedGross margin12.4%−18.2 pt vs Q3 2020
Operating margin-74.2%−31.7 pt vs Q3 2020
Net margin-75.7%−30.8 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end